EMD-34222
SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 2)
EMD-34222
Single-particle3.15 Å
![EMD-34222](https://www.ebi.ac.uk/emdb/images/entry/EMD-34222/400_34222.gif)
Map released: 26/10/2022
Last modified: 29/03/2023
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: SARS-COV-2 BA.2.75 spike glycoprotein
Deposition Authors: Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
Sample: SARS-COV-2 BA.2.75 spike glycoprotein
Deposition Authors: Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant.
Saito A
,
Tamura T
,
Zahradnik J,
Deguchi S,
Tabata K
,
Anraku Y,
Kimura I,
Ito J,
Yamasoba D,
Nasser H,
Toyoda M,
Nagata K,
Uriu K,
Kosugi Y,
Fujita S
,
Shofa M
,
Monira Begum M,
Shimizu R,
Oda Y,
Suzuki R,
Ito H,
Nao N,
Wang L,
Tsuda M,
Yoshimatsu K,
Kuramochi J,
Kita S,
Sasaki-Tabata K,
Fukuhara H,
Maenaka K,
Yamamoto Y,
Nagamoto T,
Asakura H,
Nagashima M,
Sadamasu K,
Yoshimura K,
Ueno T
,
Schreiber G,
Takaori-Kondo A,
Shirakawa K,
Sawa H
,
Irie T,
Hashiguchi T,
Takayama K,
Matsuno K
,
Tanaka S,
Ikeda T,
Fukuhara T
,
Sato K
(2022) Cell Host Microbe , 30 , 1540 - 1555.e15
![](http://www.ebi.ac.uk/web_guidelines/images/logos/orcid/orcid_16x16.png)
![](http://www.ebi.ac.uk/web_guidelines/images/logos/orcid/orcid_16x16.png)
![](http://www.ebi.ac.uk/web_guidelines/images/logos/orcid/orcid_16x16.png)
![](http://www.ebi.ac.uk/web_guidelines/images/logos/orcid/orcid_16x16.png)
![](http://www.ebi.ac.uk/web_guidelines/images/logos/orcid/orcid_16x16.png)
![](http://www.ebi.ac.uk/web_guidelines/images/logos/orcid/orcid_16x16.png)
![](http://www.ebi.ac.uk/web_guidelines/images/logos/orcid/orcid_16x16.png)
![](http://www.ebi.ac.uk/web_guidelines/images/logos/orcid/orcid_16x16.png)
![](http://www.ebi.ac.uk/web_guidelines/images/logos/orcid/orcid_16x16.png)
(2022) Cell Host Microbe , 30 , 1540 - 1555.e15